Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.4184
+0.0312 (8.06%)
At close: Nov 13, 2026, 4:00 PM EST
0.4252
+0.0068 (1.63%)
After-hours: Nov 13, 2026, 7:47 PM EST
Ensysce Biosciences Employees
As of December 31, 2025, Ensysce Biosciences had 10 total employees, including 8 full-time and 2 part-time employees. The number of employees increased by 2 or 25.00% compared to the previous year. That makes Ensysce Biosciences the 40,336th largest employer in the world and 6,028th in the United States.
Employees
10
Change (1Y)
2
Growth (1Y)
25.00%
Revenue / Employee
$618,928
Profits / Employee
-$9,121,289
Market Cap
8.14M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 10 | 2 | 25.00% | 8 | 2 |
| Dec 31, 2024 | 8 | 1 | 14.29% | 7 | 1 |
| Dec 31, 2023 | 7 | 0 | - | 7 | 0 |
| Dec 31, 2022 | 7 | 1 | 16.67% | 7 | 0 |
| Dec 31, 2021 | 6 | 3 | 100.00% | 6 | 0 |
| Sep 30, 2021 | 4 | 1 | 33.33% | 4 | 0 |
| Jun 30, 2021 | 4 | - | - | 4 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 41 |
| Longeveron | 38 |
| IN8bio | 20 |
| Moleculin Biotech | 17 |
| CalciMedica | 15 |
| Soligenix | 14 |
| Kiora Pharmaceuticals | 13 |
| Immuron | 8 |
ENSC News
- 3 days ago - Ensysce Biosciences Earnings release: Q3 2026 - Filings
- 3 days ago - Ensysce Biosciences Quarterly report: Q3 2026 - Filings
- 3 days ago - Ensysce Biosciences Proxy statement: Proxy filing - Filings
- 3 days ago - Ensysce Biosciences initiated with a Buy at UBS - TheFly
- 16 days ago - Ensysce Biosciences Proxy statement: Proxy filing - Filings
- 23 days ago - Ensysce Biosciences registers to sell 433.91M shares of common stock for holders - TheFly
- 23 days ago - Ensysce Biosciences Registration statement: Registration filing - Filings
- 25 days ago - Ensysce Biosciences participates in Family Office Summit, Dubai - TheFly